SCHEMBL2005219

SCHEMBL2005219

CC1=Nc2ccc(CC(=O)O)cc2C1(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 5/20 0.41
KDM4E B2RXH2 4/20 0.41
HPGD P15428 4/20 0.41
HSD17B10 Q99714 4/20 0.41
MAPT P10636 3/20 0.41
TSHR P16473 3/20 0.41
NFKB1 P19838 2/20 0.41
TDP1 Q9NUW8 2/20 0.41
RGS12 O14924 1/20 0.41
LMNA P02545 1/20 0.41
POLB P06746 1/20 0.41
APEX1 P27695 1/20 0.41
THPO P40225 1/20 0.41
BLM P54132 1/20 0.41
GNAI1 P63096 1/20 0.41
PMP22 Q01453 1/20 0.41
HIF1A Q16665 1/20 0.41
RXRA P19793 1/20 0.41
RXRB P28702 1/20 0.41
RXRG P48443 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8390740 0.88 CA2 (0.40) KDM4EHPGDMAPTNFKB1LMNA
SCHEMBL8390737 0.87 MEN1 (0.32) MEN1KMT2A
SCHEMBL14048572 0.85 CYP26B1 (0.46) CYP26A1CYP26B1
SCHEMBL8328904 0.84 ALDH1A1 (0.44) GAAKDM4EHPGDMAPTTSHR
SCHEMBL18386310 0.83 SMN1; SMN2 (0.42) MAPTNFKB1LMNAMEN1KMT2A
SCHEMBL28870507 0.76 TDP1 (0.41) GAATDP1BLMRXRARXRB
SCHEMBL29367860 0.76 TDP1 (0.41) GAATDP1BLMRXRARXRB
SCHEMBL2066598 0.76 CA5A (0.35) GAAKDM4EHPGDHSD17B10MAPT
SCHEMBL5556297 0.73 GRIN2D (0.33)
SCHEMBL5851116 0.73 SKP2 (0.41) KDM4EHSD17B10LMNAHIF1AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260053393-A1 NEAR-IR GLUCOSE SENSORS PROFUSA INC (US) 2026-02-26 US disclosed
US-20250230174-A1 NEAR-IR GLUCOSE SENSORS PROFUSA, INC. (US) 2025-07-17 US disclosed
US-12285250-B2 Near-IR glucose sensors PROFUSA, INC (US) 2025-04-29 US disclosed
EP-3309552-B1 DYE COMPOUND SFC CO LTD (KR) 2024-01-17 EP disclosed
EP-3813667-A1 NEAR-IR GLUCOSE SENSORS Profusa, Inc. (US) 2021-05-05 EP disclosed
US-20210101915-A1 NEAR-IR GLUCOSE SENSORS PROFUSA, INC. (US) 2021-04-08 US disclosed
US-20210101915-A1 NEAR-IR GLUCOSE SENSORS PROFUSA, INC. (US) 2021-04-08 US disclosed
CN-112601491-A Near-infrared glucose sensor 普罗菲尤萨股份有限公司 2021-04-02 CN disclosed
US-10717751-B2 Near-IR glucose sensors PROFUSA, INC. (US) 2020-07-21 US disclosed
US-10717751-B2 Near-IR glucose sensors PROFUSA, INC. (US) 2020-07-21 US disclosed
EP-1252520-A2 METHODS EMPLOYING INCREASED DYE-FLUORESCENCE UPON NITROREDUCTION Amersham Biosciences UK Limited (GB) 2002-10-30 EP disclosed
EP-1212375-A2 PH SENSITIVE CYANINE DYES AS REACTIVE FLUORESCENT REAGENTS CARNEGIE-MELLON UNIVERSITY (US) 2002-06-12 EP disclosed
WO-2000075237-A9 pH SENSITIVE CYANINE DYES AS REACTIVE FLUORESCENT REAGENTS UNIV CARNEGIE MELLON (US) 2002-05-10 WO disclosed
WO-2002029407-A2 DYE-LABELLED PEPTIDE AND ITS DIAGNOSTIC USE AMERSHAM BIOSCIENCES UK LTD. (GB) 2002-04-11 WO disclosed
EP-1042407-B1 RIGIDIZED TRIMETHINE CYANINE DYES UNIV CARNEGIE MELLON (US) 2001-09-12 EP disclosed
WO-2001057237-A2 METHODS EMPLOYING INCREASED DYE-FLUORESCENCE UPON NITROREDUCTION AMERSHAM BIOSCIENCES UK LIMITED (GB) 2001-08-09 WO disclosed
WO-2000075237-A2 pH SENSITIVE CYANINE DYES AS REACTIVE FLUORESCENT REAGENTS CARNEGIE MELLON UNIVERSITY (US) 2000-12-14 WO disclosed
US-6133445-A USEFUL FOR IMPARTING FLUORESCENT PROPERTIES TO TARGET MATERIALS CARNEGIE MELLON UNIVERSITY (US) 2000-10-17 US disclosed
EP-1042407-A1 RIGIDIZED TRIMETHINE CYANINE DYES CARNEGIE-MELLON UNIVERSITY (US) 2000-10-11 EP disclosed
WO-1999031181-A1 RIGIDIZED TRIMETHINE CYANINE DYES CARNEGIE MELLON UNIVERSITY (US) 1999-06-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250230174-A1 NEAR-IR GLUCOSE SENSORS IRS1, INSR, SLC2A4 GAA 155/4885KDM4E 3160/4885HPGD 3387/4885
US-20210101915-A1 NEAR-IR GLUCOSE SENSORS IRS1, INSR, SLC2A4 GAA 155/4885KDM4E 3160/4885HPGD 3387/4885
US-20260053393-A1 NEAR-IR GLUCOSE SENSORS INSR, IRS1, SLC2A4 GAA 2580/4885KDM4E 3774/4885HPGD 4462/4885
US-12285250-B2 Near-IR glucose sensors IRS1, SLC2A4, GPR119 GAA 182/4885KDM4E 1818/4885HPGD 2318/4885
US-10717751-B2 Near-IR glucose sensors IRS1, G6PD, SLC2A8 GAA 55/4885KDM4E 1515/4885HPGD 760/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.